Tirzepatide Significantly Improves Quality of Life for Japanese Adults with Obesity
Effect of Tirzepatide on Health-Related Quality of Life in Japanese Patients With Obesity Disease: Patient-Reported Outcomes From the SURMOUNT-J Study.
Background
Obesity disease significantly impairs health-related quality of life (HR-QoL), leading to physical, psychological, and social challenges. While tirzepatide has demonstrated efficacy in weight management, its specific impact on HR-QoL (a measure of overall well-being and daily functioning) in Japanese patients without diabetes has not been fully elucidated. This study aimed to evaluate the effect of tirzepatide on HR-QoL in this specific population.
Study Design
Population
Japanese adults with obesity disease, without diabetes.
Intervention
Tirzepatide, dose, route, and duration not specified in the digest.
Outcome
The effect of tirzepatide on health-related quality of life (HR-QoL).
